Monday, July 27, 2015

California Prisons Aim To Keep Sex Between Inmates Safe

California Prisons Aim To Keep Sex Between Inmates Safe, If Illegal




There's an inconspicuous metal box mounted on the wall of the gym at San Francisco County Jail No. 4.
When Kate Monico Klein turns a knob, the machine releases a condom in a small cardboard packet. Machines like this one — dispensing free condoms — are installed in all of the county's male jails.
"We set [the machine] off to the side, so that people would have a minor amount of privacy," explains Monico Klein, director of HIV services for Jail Health, a division of the county's health department.
San Francisco has been distributing condoms to inmates in county jails for decades, but a new California law requires condoms to be made available to all state prisoners. California is the second state after Vermont to do so, even though sex between prisoners is unlawful here.
"I get about 10 of them every time," says Jail No. 4 inmate Robert Greve, with a laugh. He has been in and out of prison in several states, but this is the first time Greve has been locked up somewhere that provided condoms.
"Condoms are very good to have around, I think, you know? Because it's a lifesaving device," he says. "A lot of people don't care about their health, I think."
But even though condoms are available inside the jail, Greve says deputies still enforce rules against inmates having sex.
"They freak out about it — like, I've seen them catch people in bed together and they're like, 'Hey, what are you doing?!' "
The Centers for Disease Control and Prevention estimates that 1 in 7 people living with HIV passes through correctional facilities each year."We still have the need of sex, and believe it or not the straight men, while they're in custody, they do have sexual activity with other males," Angel Ramirez says. "It's sad, because I heard from other inmates how they ... get infected with HIV while in custody."Inmate Rene Angel Ramirez, who is gay and HIV-positive, says condoms keep his partners safer and protect him from other diseases like gonorrhea, chlamydia or hepatitis C.
Back in the 1980s, San Francisco became one of the first places in the country to hand out condoms to inmates in the county jail. But three decades later, it's still one of only a handful of prison and jails in the country that do so.
Often that's for a simple reason: Sex in prison or jails is against the rules in every state, even if it's consensual. And in some states, including California, it's actually a crime.
Still, San Francisco Sheriff Ross Mirkarimi says he supports the condom distribution program if it helps slow the spread of HIV and other sexually transmitted diseases.
"The law is the law," he says. "But should this behavior occur ... there is a safer way. We want people to be protected — and we insist on it, that they be protected."
But not all deputies are comfortable with condoms being available.
"I could not report to you that there still is buy-in from the uniformed staff," says Matthew Freeman, San Francisco's chief deputy sheriff. There are reasons that even consensual sex is prohibited in jail, he says.
"We know from our experiences running and managing these county jails that even consensual sexual activity amongst inmates can lead to very real problems," he says, like disharmony in the jail, which the sheriff's department says is a potential security risk.
In the early days, deputies also were concerned that condoms could be used as weapons or to smuggle drugs. And while Monico Klein of the public health department says that hasn't happened, she adds that condoms have been put to some more unusual uses.
"We found that, among other things, the prisoners take the condoms and they use them as hair ties, they use them as pillows," she says. "One of the deputies told me that they blow them up and use them as balloons."
And although that initially bothered some people, she says, "one of the things we realized is that it is another way of destigmatizing HIV."
California's state prison system now has five years to come up with a plan to provide condoms in all of its facilities.

Tuesday, July 14, 2015

The Story Behind Okamoto

totalaccessgroup.com   |   specials   |   new products   |   pricing   |   blog  |   about us

The Story Behind Okamoto

Okamoto Condoms are #1 for a Reason!

In the United States there are brands that everyone is familiar with. Why is that?
Great Feel? Trustworthy? Reliability? Market share? Brand marketing?
The true answer is a combination of all of these.
One thing for sure is when you try a condom and don't like it you NEVER go back. However, if you like it, you ALWAYS go back to it.

The fact that Okamoto is the #1 Top Selling Brand in Japan means they have HUGE consumer satisfaction. While they may not be as well known here in the US as some other brands, their #1 position in Japan is proof they are great choice!

 This Japanese Company has dedicated itself to insure the highest standard of
QUALITY for all of its products.

Okamoto has been innovating for nearly 80 years,
producing the world's THINNEST, SOFTEST and SAFEST condoms.
Think QUALITY... Think OKAMOTO!

Special Savings this Month on all Bulk Okamoto Condoms!

Don't Miss it!

  • Aqua tinted latex appears clear when donned
  • Strong and durable, yet sensitive
Reg. $79.00 1008/case

NOW $74.00
SAVE $5.00



  • Lightly lubricated, lightly tinted blue latex
  • Studded texture helps increase the sensation for both partners
Reg. $82.00 1008/case

NOW $74.00
SAVE $8.00


  • Made with four times more lubricant than other condoms
  • Aloe helps prevent irritation and pain,  and helps retain moisture
Reg. $135.00 1008/case

NOW $120.00
SAVE $15.00


  • One of the best rated condoms used in the public health industry
  • Super thin with a coral tint, appears clear when donned
​Reg. $73.00 1008/case

NOW $66.00
SAVE $7.00

  • A variety of colors including blue, red/pink, yellow, and green
  • One of the thinnest assorted color condoms on the market
​Reg. $74.00 1008/case

NOW $69.00
SAVE $5.00

.004 are made of high-tech latex called Sheerlon® and are thinner than all other comparable product in the market! The fact is, when you’re wearing almost nothing, you’re going to feel everything!
Find out more about the .004 

                                    

Pedro Carmona
Account Manager
1671 E Saint Andrew Pl,  Santa Ana, CA 92705
tel 714.259.9200 ext. 235 / 800.320.3716
fax 714.259.9202

Wednesday, July 8, 2015

Recent Increase in Heroin Usage in U.S.

Health officials, confronted with a shocking increase in heroin abuse, are developing a clearer picture of who is becoming addicted to this drug and why. The results may surprise you.
The biggest surge is among groups that have historically lower rates of heroin abuse: women and white (non-Hispanic) Americans. They tend to be 18-25 years old, with household incomes below $20,000. "In addition, persons using heroin are abusing multiple other substances, especially cocaine and opioid pain relievers," says a reportpublished Tuesday by the Centers for Disease Control and Prevention.
All told, more than half a million Americans used heroin in 2013, according to the report. That represents a nearly 150 percent increase since 2007.
Men still outnumber women, but that gap is narrowing. And 96 percent of heroin users said they'd used other drugs within the past year.
In 2013 alone, more than 8,200 Americans died of heroin overdoses. Most of them took that as a deadly combination with other drugs — most often cocaine. The death toll has skyrocketed in recent years. It's up from 1,800 in 2001, according to a reportfrom the National Institute on Drug Abuse.
"As a doctor who started my career taking care of patients with HIV and other complications from injection drugs, it's heartbreaking to see injection drug use making a comeback in the U.S.," says Dr. Tom Frieden, head of the CDC. He unveiled the report in a phone briefing.
Those stark facts define the challenge that health officials face. The epidemic isn't just a problem of inner city "shooting galleries" and a dead end for the down-and-out. To a considerable extent, Frieden says the heroin "crisis" is growing out of prescription drug abuse, especially opioid painkiller use. People who abuse painkillers are 40 times more likely to abuse or be dependent on heroin, the study finds.
"It's really a one-two punch," Frieden said.
First, he says, the widespread use of opiate painkillers has primed people for heroin addiction. These drugs and heroin have essentially the same active ingredient. The second punch is that heroin is increasingly available, and often far cheaper than prescription painkillers. Frieden estimates that heroin is available on the street at one-fifth the cost of prescription pain pills.
This problem calls for a comprehensive response — one that recognizes the changing demographics of heroin use, says the CDC report, which is co-authored by Christopher Jones at the Food and Drug Administration along with colleagues from the CDC.
Frieden said "an urgent all-society response" is needed. It would include:
  • Tracking the use of prescription painkillers and making sure doctors only prescribe them as necessary.
  • Providing treatment to individuals who are addicted to these drugs.
  • Cracking down on smuggling and street sales of heroin, to drive up the price and discourage abuse.
  • Increasing the use of naloxone, a drug that can be injected into someone with a heroin overdose to reduce the risk of death.
For the full article, please visit National Public Radio's website at the link below:

Friday, June 26, 2015

NEWS: Huge Breakthrough!

STUDENTS CREATE CONCEPTUAL CONDOM THAT CHANGES COLORS TO INDICATE STD EXPOSURE



For the Full Story, Check out the article on ABC 7's website by clicking the link below:

Teenage students are pitching a conceptual invention to help curb the spread of STDs: a condom that changes colors when exposed to sexually transmitted diseases and infections.

Students Daanyaal Ali, 14, Muaz Nawaz, 13, and Chirag Shah, 14 of England's Isaac Newton Academy created a "smart condom" concept they're calling S.T. EYE, according to The Washington Post. The students delivered their research project to U.K.'s TeenTech Awards which aims to "help young teenagers see the wide range of career possibilities in Science, Engineering and Technology (STEM).

The conceptual prophylactic would be coated in antibodies that would interact with the antigens of an STD, causing the luminescent hue to change colors. The students said they believe the condom would be able to help identify exposure to chlamydia, herpes, HPV and syphilis all with different colors.

"We knew that STIs were a huge problem in the U.K.," Daanyaal told The Washington Post. "We saw a gap in the market and we wanted to help people feel safer."

The three young boys won top honors at the TeenTech Awards, winning a cash prize equivalent to around $1,500 and a trip to meet Prince Andrew at Buckingham Palace.

TeenTech chief executive Maggie Philbin said that the S.T. EYE is merely a concept right now, though some condom manufacturers have already approached the students about their research.

"We know most of these ideas remain ideas," Philbin told The Washington Post. "But some of them do make it."

Monday, May 18, 2015

HIV Vaccine Awareness Day

National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) is the lead for this day. Read and share this 2013 NIAID Bulletin about HIV Vaccine Awareness Day

http://www.niaid.nih.gov/news/newsreleases/2013/Pages/HVAD2013.aspx

The implementation of scientifically proven HIV prevention strategies is helping to reduce the number of new infections—the annual HIV infection rate globally fell by 22 percent from 2001 to 2011—but a great deal more must be done. Significant scale-up of proven HIV prevention strategies coupled with the discovery of new HIV treatment and prevention interventions are needed to achieve an end to the global HIV/AIDS pandemic. A safe, effective and durable HIV vaccine is an essential cornerstone to the long-term strategy to achieve this goal.
Developing a safe and effective HIV vaccine has been a long and difficult process largely because HIV has proven to be an especially tough target. Recent developments with the HVTN 505 clinical trial and analyses from the HVTN 503 “Phambili” vaccine study have been disappointing, but they also provided clear answers about investigational vaccine strategies that, ultimately, were not effective. Still, the new directions for HIV vaccines that have been recently initiated define our future path and will be pursued.
Among many projects, scientists continue to explore findings from the ArchiveRV 144 HIV vaccine study in Thailand, which, in 2009, provided proof-of-concept that an HIV vaccine can afford a modest level of protection. Ongoing research related to the Thai trial is providing important information about human immune responses and other factors that may explain why the investigational vaccine protected some trial volunteers from HIV infection but not others. Such data will help advance researchers’ understanding of HIV’s structure and vulnerabilities and help guide the development of future HIV vaccine candidates. Large-scale investigational vaccine clinical trials designed to build on the RV 144 results and create a more robust and durable level of protection are expected to begin in two-to-three years in South Africa.
In basic research, scientists are making important discoveries about broadly neutralizing antibodies capable of disabling a wide range of HIV strains when tested in the laboratory setting. For example, NIAID scientists recently charted the co-evolution of HIV and a strong antibody response in an HIV-infected study participant, who is one of the 20 percent of HIV-infected individuals who naturally develops broadly neutralizing antibodies to the virus after several years of infection. Their findings could help identify which proteins to use in an investigational vaccine to induce broadly neutralizing antibodies more quickly. In another advance, a team of NIH scientists recently developed a new tool to identify broadly neutralizing antibodies from blood samples, which could help speed HIV vaccine research.
Other interesting basic research findings have included the identification of a new HIV-suppressing protein, called CXCL4, in the blood of HIV-infected individuals. NIAID scientists found that CXCL4 binds to HIV in such a way that the virus cannot attach or enter a human cell, leading to the conclusion that it may serve to regulate viral replication in an infected individual and, therefore, control the pace at which HIV disease progresses. Additionally, NIAID researchers found that even though HIV diversifies widely in infected individuals over time, the virus strains that are passed on through heterosexual transmission often resemble the strain that originally infected the transmitting partner. Learning more about the characteristics of these dominant strains could help inform HIV vaccine design.

Recent NIAID investments in basic research toward innovative HIV vaccine discovery research and vaccine immunology and immunogen discovery should also prove fruitful in the coming years for HIV vaccine research.

On this HIV Vaccine Awareness Day, NIAID thanks the thousands of men and women who have selflessly volunteered for clinical studies and the scientists and clinicians working to find an effective HIV vaccine. NIAID shares your commitment and will continue the important research needed to make a protective HIV vaccine a reality.

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

Tuesday, April 7, 2015

Get Yourself Tested

Here is a piece from the "GYT (Get Yourself Tested) FAQs" page. For more questions about STD's and STD Related topics visit the link below:

Why should I get tested?

Sexually transmitted diseases (STDs, also called sexually transmitted infections or STIs) are very common. Every year there are more than 20 million new cases of STDs in the U.S. By age 25, roughly one in two sexually active people will get one. If you think it can’t happen to you…think again. Since STDs often show no symptoms, many of those infected don’t even know it. The only way to know if you or a partner has an STD is to get tested. Here’s the good news: the side effects and health outcomes of most STDs can be treated, and many are curable. Putting off getting care for an STD can have lasting health effects for both women and men. Left untreated, some STDs can cause infertility (that is, make you unable to have children). Some can also increase your risk of getting cancer. And get this-already having an STD increases your risk of getting HIV and other STDs if you have sex with an infected partner.

If you notice any changes or irritations “down there,” or any unusual discharge or discomfort when urinating, you should see a health care provider immediately as these may be signs of an STD. However, not all genital infections are STDs. STDs can often be mistaken for common infections or irritations. For example, bumps like pimples or hair follicles on or around the genitals may be confused for genital warts. Women often confuse STDs with yeast infections and other conditions. That’s why it’s important to see a health care provider, who can determine what (if any) STDs you should be tested for.
Not everyone likes to talk about their sexual history. But, before you start a new sexual relationship, it’s a good idea to talk with your partner about your sexual history and getting tested for STDs. After all, you are not just having sex with your partner but with everyone they’ve had sex with…and everyone they’ve had sex with…and well, you get the point. It can be intimidating to think about, but taking charge and getting tested will help you take control over the situation.